Hytiroglou et al., 1995 - Google Patents
Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiologyHytiroglou et al., 1995
View PDF- Document ID
- 18029731313433524387
- Author
- Hytiroglou P
- Dash S
- Haruna Y
- Fernandez M
- Theise N
- Schwartz M
- Miller C
- Bodenheimer Jr H
- Thung S
- Gerber M
- Publication year
- Publication venue
- American journal of clinical pathology
External Links
Snippet
In a significant number of patients, the etiology of fulminant hepatic failure (FHF) is unknown. To determine whether hepatitis B virus (HBV) and hepatitis C virus (HCV) play a role in patients without serologic markers of HBV and HCV infection, the authors examined tissue …
- 230000003612 virological 0 title abstract description 13
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5761—Hepatitis B
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction | |
| Wright et al. | Hepatitis B virus and apparent fulminant non-A, non-B hepatitis | |
| Wang et al. | Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus | |
| Michalak et al. | Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver | |
| Liaw et al. | Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis | |
| Fong et al. | Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease | |
| Burrell et al. | Correlation between liver histology and markers of hepatitis B virus replication in infected patients: a study by in situ hybridization | |
| Yu et al. | Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non‐Asians in Los Angeles County, California | |
| Fabris et al. | Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C | |
| Shiratori et al. | Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? | |
| Zignego et al. | “Inapparent” hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease | |
| Shouval et al. | Chronic hepatitis in chimpanzee carriers of hepatitis B virus: morphologic, immunologic, and viral DNA studies. | |
| Crespo et al. | Severe clinical course of de novo hepatitis B infection after liver transplantation | |
| Colombari et al. | Chronic hepatitis in multiple virus infection: histopathological evaluation | |
| Hytiroglou et al. | Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology | |
| Komori et al. | Long-term clinical impact of occult hepatitis B virus infection in chronic hepatitis B patients | |
| Borghesio et al. | Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon‐treated patients and in patients who underwent liver transplantation | |
| Moreno-Otero et al. | Development of Cirrhosis after Chronic Type B Hepatitis: A Clinicopathologic and Follow--up Study of 46 HBeAg--Positive Asymptomatic Patients. | |
| Tzonou et al. | Epidemiologic assessment of interactions of hepatitis‐C virus with seromarkers of hepatitis‐B and‐D viruses, cirrhosis and tobacco smoking in hepatocellular carcinoma | |
| Marrone et al. | Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection | |
| Honarkar et al. | Occult hepatitis B among chronic liver disease patients | |
| Brechot | Polymerase chain reaction for the diagnosis of viral hepatitis B and C. | |
| Verbaan et al. | Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence | |
| Kawai et al. | State of HBV DNA in HBsAg‐negative, anti‐HCV‐positive hepatocellular carcinoma: Existence of HBV DNA possibly as nonintegrated form with analysis by Alu‐HBV DNA PCR and conventional HBV PCR | |
| Novick et al. | Hepatitis D virus antibody in HBsAg‐positive and HBsAg‐negative substance abusers with chronic liver disease |